Learn more

FED GOSUDARSTVENNOE BYUDZHETNOE NAUCHNOE UCHREZHDENIE TOMSKIJ NAUCHNO-ISSLEDOVATELSKIJ INST ONKOLOGI

Overview
  • Total Patents
    17
  • GoodIP Patent Rank
    96,504
About

FED GOSUDARSTVENNOE BYUDZHETNOE NAUCHNOE UCHREZHDENIE TOMSKIJ NAUCHNO-ISSLEDOVATELSKIJ INST ONKOLOGI has a total of 17 patent applications. Its first patent ever was published in 2015. It filed its patents most often in Russian Federation. Its main competitors in its focus markets medical technology, measurement and pharmaceuticals are ALBERTA CANCER BOARD, THERALASE TECH INC and RAND ROBERT W.

Patent filings in countries

World map showing FED GOSUDARSTVENNOE BYUDZHETNOE NAUCHNOE UCHREZHDENIE TOMSKIJ NAUCHNO-ISSLEDOVATELSKIJ INST ONKOLOGIs patent filings in countries
# Country Total Patents
#1 Russian Federation 17

Patent filings per year

Chart showing FED GOSUDARSTVENNOE BYUDZHETNOE NAUCHNOE UCHREZHDENIE TOMSKIJ NAUCHNO-ISSLEDOVATELSKIJ INST ONKOLOGIs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Slonimskaya Elena Mikhajlovna 7
#2 Litvyakov Nikolaj Vasilevich 6
#3 Zavyalova Marina Viktorovna 4
#4 Startseva Zhanna Aleksandrovna 4
#5 Afanasev Sergej Gennadevich 3
#6 Tuzikov Sergej Aleksandrovich 3
#7 Cheremisina Olga Vladimirovna 3
#8 Dobrodeev Aleksej Yurevich 3
#9 Denisov Evgenij Vladimirovich 2
#10 Cherdyntseva Nadezhda Viktorovna 2

Latest patents

Publication Filing date Title
RU2623118C1 Method for prediction of full regression probability during neoadjuvant chemotherapy in patients with three-times negative molecular-genetic subtype of breast cancer
RU2632112C1 Method for prediction of degree of full regression probability during neoadjuvant chemotherapy in patients with luminal molecular-genetic subtype of breast cancer
RU2623119C1 Method for distant metastases development risk degree determination for patients with colon cancer
RU2623150C1 Method for hematogenous metastasis prediction in case of non-specific invasive breast carcinoma for patients with bad response to neoadjuvant chemotherapy
RU2627649C1 Method for hematogenic metastasing prediction in case of non-specific invasive carcinoma of breast in patients with good response to neoadjuvant chemotherapy
RU2621381C1 Method for lung ventilation during thoracic surgery in lung cancer patients with concomitant chronic obstructive pulmonary disease
RU2616533C1 Method for everolimus therapy efficiency prediction for patients with metastatic renal cancer
RU2622633C1 Method for combined thermal chemo-radial treatment of patients with locally advanced cervical cancer
RU2627289C1 Method for anesthetic maintenance during radical surgery for cancer patients
RU2616182C1 Method for prevention of nasolacrimal ways impaired patency after removal nasal cavity and sinuses tumours
RU2599043C1 Method of combination treatment of locally advanced rectal cancer
RU2599042C1 Method of treating radioreactions of eye tissues and eye region skin during radiation therapy in oncological patients
RU2594251C1 Method for personalized assignment of neoajuvant chemotherapy to patients suffering from luminal type b breast cancer
RU2599209C1 Method of prediction of risk probability of development of anastomotic breakdown in post- surgery period at patients suffering with oesophageal cancer
RU2607177C1 Method of treating chronic rhinitis and inflammation of paranasal sinuses in oncological patients
RU2607961C2 Method of treating recurrent soft tissue sarcomas using local hyperthermia
RU2593342C1 Method of combination treatment of non-small cell lung cancer stage 1b-111 with customization of adjuvant chemotherapy